{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:05:28Z","timestamp":1772165128572,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T00:00:00Z","timestamp":1447718400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Special Coordination Funds for Promoting Science and Technology from the Japanese Ministry of Education, Culture, Sports, Science and Technology"},{"name":"programs for promoting clinical cancer research through a Japanese Health and Labor Sciences Research Grant"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s10147-015-0925-1","type":"journal-article","created":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T06:40:31Z","timestamp":1447742431000},"page":"523-530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial)"],"prefix":"10.1007","volume":"21","author":[{"given":"Seiki","family":"Hasegawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morihito","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumihiro","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeharu","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshinori","family":"Soejima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Kamikonya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Tsujimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Fukuoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Yokoi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,17]]},"reference":[{"key":"925_CR1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","volume":"366","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Musk AW, Lake RA (2005) Malignant mesothelioma. Lancet 366:397\u2013408","journal-title":"Lancet"},{"issue":"Suppl 2","key":"925_CR2","first-page":"ii1","volume":"62","author":"Committee BTSSoC","year":"2007","unstructured":"Committee BTSSoC (2007) BTS statement on malignant mesothelioma in the UK, 2007. Thorax 62(Suppl 2):ii1\u2013ii19","journal-title":"Thorax"},{"key":"925_CR3","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1056\/NEJMra050152","volume":"353","author":"BW Robinson","year":"2005","unstructured":"Robinson BW, Lake RA (2005) Advances in malignant mesothelioma. N Engl J Med 353:1591\u20131603","journal-title":"N Engl J Med"},{"key":"925_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajim.20246","volume":"49","author":"T Murayama","year":"2006","unstructured":"Murayama T, Takahashi K, Natori Y et al (2006) Estimation of future mortality from pleural malignant mesothelioma in Japan based on an age-cohort model. Am J Ind Med 49:1\u20137","journal-title":"Am J Ind Med"},{"key":"925_CR5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12199-007-0016-7","volume":"13","author":"T Nakano","year":"2008","unstructured":"Nakano T (2008) Current therapies for malignant pleural mesothelioma. Environ Health Prev Med 13:75\u201383","journal-title":"Environ Health Prev Med"},{"key":"925_CR6","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1289\/ehp.1002845","volume":"119","author":"EK Park","year":"2011","unstructured":"Park EK, Takahashi K, Hoshuyama T et al (2011) Global magnitude of reported and unreported mesothelioma. Environ Health Perspect 119:514\u2013518","journal-title":"Environ Health Perspect"},{"key":"925_CR7","first-page":"491","volume":"1","author":"BM Robinson","year":"2012","unstructured":"Robinson BM (2012) Malignant pleural mesothelioma: an epidemiological perspective. Ann Cardiothorac Surg 1:491\u2013496","journal-title":"Ann Cardiothorac Surg"},{"key":"925_CR8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/jjco\/hyn145","volume":"39","author":"T Yamanaka","year":"2009","unstructured":"Yamanaka T, Tanaka F, Hasegawa S et al (2009) A feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation for malignant pleural mesothelioma. Jpn J Clin Oncol 39:186\u2013188","journal-title":"Jpn J Clin Oncol"},{"key":"925_CR9","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1378\/chest.108.4.1122","volume":"108","author":"VW Rusch","year":"1995","unstructured":"Rusch VW (1995) A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest 108:1122\u20131128","journal-title":"Chest"},{"key":"925_CR10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1556-0864(15)31536-7","volume":"1","author":"DJ Sugarbaker","year":"2006","unstructured":"Sugarbaker DJ (2006) Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma. J Thorac Oncol 1:175\u2013176","journal-title":"J Thorac Oncol"},{"key":"925_CR11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/annonc\/mdh059","volume":"15","author":"MJ Byrne","year":"2004","unstructured":"Byrne MJ, Nowak AK (2004) Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 15:257\u2013260","journal-title":"Ann Oncol"},{"key":"925_CR12","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/0003-4975(92)90654-M","volume":"54","author":"DJ Sugarbaker","year":"1992","unstructured":"Sugarbaker DJ, Mentzer SJ, Strauss G (1992) Extrapleural pneumonectomy in the treatment of malignant pleural mesothelioma. Ann Thorac Surg 54:941\u2013946","journal-title":"Ann Thorac Surg"},{"key":"925_CR13","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1067\/mtc.2001.116560","volume":"122","author":"VW Rusch","year":"2001","unstructured":"Rusch VW, Rosenzweig K, Venkatraman E et al (2001) A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 122:788\u2013795","journal-title":"J Thorac Cardiovasc Surg"},{"key":"925_CR14","unstructured":"Common Terminology Criteria for Adverse Events, version 4.0 (CTCAEv4.0) (2009). http:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctchtm#ctc_40"},{"key":"925_CR15","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1200\/JCO.2004.10.071","volume":"22","author":"W Weder","year":"2004","unstructured":"Weder W, Kestenholz P, Taverna C et al (2004) Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. J Clin Oncol 22:3451\u20133457","journal-title":"J Clin Oncol"},{"key":"925_CR16","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1556-0864(15)31583-5","volume":"1","author":"RM Flores","year":"2006","unstructured":"Flores RM, Krug LM, Rosenzweig KE et al (2006) Induction chemotherapy, extrapleural pneumonectomy, and postoperative high-dose radiotherapy for locally advanced malignant pleural mesothelioma: a phase II trial. J Thorac Oncol 1:289\u2013295","journal-title":"J Thorac Oncol"},{"key":"925_CR17","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/annonc\/mdm093","volume":"18","author":"W Weder","year":"2007","unstructured":"Weder W, Stahel RA, Bernhard J et al (2007) Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Oncol 18:1196\u20131202","journal-title":"Ann Oncol"},{"key":"925_CR18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.lungcan.2007.02.004","volume":"57","author":"F Rea","year":"2007","unstructured":"Rea F, Marulli G, Bortolotti L et al (2007) Induction chemotherapy, extrapleural pneumonectomy (EPP) and adjuvant hemi-thoracic radiation in malignant pleural mesothelioma (MPM): feasibility and results. Lung Cancer 57:89\u201395","journal-title":"Lung Cancer"},{"key":"925_CR19","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1200\/JCO.2008.20.3943","volume":"27","author":"LM Krug","year":"2009","unstructured":"Krug LM, Pass HI, Rusch VW et al (2009) Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 27:3007\u20133013","journal-title":"J Clin Oncol"},{"key":"925_CR20","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1183\/09031936.00039510","volume":"36","author":"PE Schil Van","year":"2010","unstructured":"Van Schil PE, Baas P, Gaafar R et al (2010) Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. Eur Respir J 36:1362\u20131369","journal-title":"Eur Respir J"},{"key":"925_CR21","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","volume":"12","author":"T Treasure","year":"2011","unstructured":"Treasure T, Lang-Lazdunski L, Waller D et al (2011) Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 12:763\u2013772","journal-title":"Lancet Oncol"},{"key":"925_CR22","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1002\/(SICI)1097-0142(19990601)85:11<2375::AID-CNCR12>3.0.CO;2-E","volume":"85","author":"T Nakano","year":"1999","unstructured":"Nakano T, Chahinian AP, Shinjo M et al (1999) Cisplatin in combination with irinotecan in the treatment of patients with malignant pleural mesothelioma: a pilot phase II clinical trial and pharmacokinetic profile. Cancer 85:2375\u20132384","journal-title":"Cancer"},{"key":"925_CR23","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/jjco\/hyn024","volume":"38","author":"K Nakagawa","year":"2008","unstructured":"Nakagawa K, Yamazaki K, Kunitoh H et al (2008) Efficacy and safety of pemetrexed in combination with cisplatin for malignant pleural mesothelioma: a phase I\/II study in Japanese patients. Jpn J Clin Oncol 38:339\u2013346","journal-title":"Jpn J Clin Oncol"},{"key":"925_CR24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jamcollsurg.2011.12.024","volume":"214","author":"HM Parsons","year":"2012","unstructured":"Parsons HM, Habermann EB, Stain SC et al (2012) What happens to racial and ethnic minorities after cancer surgery at American College of Surgeons National Surgical Quality Improvement Program hospitals? J Am Coll Surg 214:539\u2013547 (discussion 547\u2013549)","journal-title":"J Am Coll Surg"},{"key":"925_CR25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s11748-012-0128-x","volume":"60","author":"R Sakata","year":"2012","unstructured":"Sakata R, Kuwano H, Yokomise H (2012) Hospital volume and outcomes of cardiothoracic surgery in Japan: 2005\u20132009 national survey. Gen Thorac Cardiovasc Surg 60:625\u2013638","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"925_CR26","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jtcvs.2007.07.060","volume":"135","author":"DJ Boffa","year":"2008","unstructured":"Boffa DJ, Allen MS, Grab JD et al (2008) Data from The Society of Thoracic Surgeons General Thoracic Surgery database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg 135:247\u2013254","journal-title":"J Thorac Cardiovasc Surg"},{"key":"925_CR27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1749-8090-4-41","volume":"4","author":"ES Powell","year":"2009","unstructured":"Powell ES, Pearce AC, Cook D et al (2009) UK pneumonectomy outcome study (UKPOS): a prospective observational study of pneumonectomy outcome. J Cardiothorac Surg 4:41","journal-title":"J Cardiothorac Surg"},{"key":"925_CR28","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s11748-014-0389-7","volume":"62","author":"S Hasegawa","year":"2014","unstructured":"Hasegawa S (2014) Extrapleural pneumonectomy or pleurectomy\/decortication for malignant pleural mesothelioma. Gen Thorac Cardiovasc Surg 62:516\u2013521","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"925_CR29","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/JTO.0b013e31824de2dc","volume":"7","author":"S Bolukbas","year":"2012","unstructured":"Bolukbas S, Eberlein M, Schirren J (2012) Prospective study on functional results after lung-sparing radical pleurectomy in the management of malignant pleural mesothelioma. J Thorac Oncol 7:900\u2013905","journal-title":"J Thorac Oncol"},{"key":"925_CR30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/0218492312454017","volume":"21","author":"T Ploenes","year":"2013","unstructured":"Ploenes T, Osei-Agyemang T, Krohn A et al (2013) Changes in lung function after surgery for mesothelioma. Asian Cardiovasc Thorac Ann 21:48\u201355","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"925_CR31","doi-asserted-by":"crossref","first-page":"620e1-3","DOI":"10.1016\/j.jtcvs.2007.10.054","volume":"135","author":"RM Flores","year":"2008","unstructured":"Flores RM, Pass HI, Seshan VE et al (2008) Extrapleural pneumonectomy versus pleurectomy\/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 135:620e1-3\u2013626e1-3","journal-title":"J Thorac Cardiovasc Surg"},{"key":"925_CR32","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1097\/JTO.0b013e31826915f1","volume":"7","author":"VW Rusch","year":"2012","unstructured":"Rusch VW, Giroux D, Kennedy C et al (2012) Initial analysis of the international association for the study of lung cancer mesothelioma database. J Thorac Oncol 7:1631\u20131639","journal-title":"J Thorac Oncol"},{"key":"925_CR33","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1200\/JCO.1994.12.6.1156","volume":"12","author":"V Rusch","year":"1994","unstructured":"Rusch V, Saltz L, Venkatraman E et al (1994) A phase II trial of pleurectomy\/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol 12:1156\u20131163","journal-title":"J Clin Oncol"},{"key":"925_CR34","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1200\/JCO.2005.04.6813","volume":"24","author":"WG Richards","year":"2006","unstructured":"Richards WG, Zellos L, Bueno R et al (2006) Phase I to II study of pleurectomy\/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. J Clin Oncol 24:1561\u20131567","journal-title":"J Clin Oncol"},{"key":"925_CR35","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/jjco\/hyt035","volume":"43","author":"M Shimokawa","year":"2013","unstructured":"Shimokawa M, Hasegawa S, Fukuoka K et al (2013) A feasibility study of induction pemetrexed plus cisplatin followed by pleurectomy\/decortication aimed at macroscopic complete resection for malignant pleural mesothelioma. Jpn J Clin Oncol 43:575\u2013578","journal-title":"Jpn J Clin Oncol"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-015-0925-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-015-0925-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-015-0925-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T19:06:43Z","timestamp":1553627203000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-015-0925-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,17]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["925"],"URL":"https:\/\/doi.org\/10.1007\/s10147-015-0925-1","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,17]]}}}